V. Rivera, G. Gao, and R. Grant, Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer, Blood, vol.105, issue.4, pp.1424-1430, 2005.
DOI : 10.1182/blood-2004-06-2501

K. Stieger, L. Meur, G. Lasne, and F. , Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors, Molecular Therapy, vol.13, issue.5, pp.967-975, 2006.
DOI : 10.1016/j.ymthe.2005.12.001

K. Warrington, . Jr, and R. Herzog, Treatment of human disease by adeno-associated viral gene transfer, Human Genetics, vol.5, issue.2, pp.571-603, 2006.
DOI : 10.1111/j.1349-7006.2002.tb01262.x

G. Niemeyer, R. Herzog, and J. Mount, Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy, Blood, vol.113, issue.4, pp.797-806, 2009.
DOI : 10.1182/blood-2008-10-181479

R. Herzog, J. Mount, and V. Arruda, Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null Mutation, Molecular Therapy, vol.4, issue.3, pp.192-200, 2001.
DOI : 10.1006/mthe.2001.0442

D. Favre, V. Blouin, and N. Provost, Lack of an Immune Response against the Tetracycline-Dependent Transactivator Correlates with Long-Term Doxycycline-Regulated Transgene Expression in Nonhuman Primates after Intramuscular Injection of Recombinant Adeno-Associated Virus, Journal of Virology, vol.76, issue.22, pp.11605-11611, 2002.
DOI : 10.1128/JVI.76.22.11605-11611.2002

P. Chenuaud, T. Larcher, and J. Rabinowitz, Autoimmune anemia in macaques following erythropoietin gene therapy, Blood, vol.103, issue.9, pp.3303-3304, 2004.
DOI : 10.1182/blood-2003-11-3845

G. Gao, C. Lebherz, and D. Weiner, Erythropoietin gene therapy leads to autoimmune anemia in macaques, Blood, vol.103, issue.9, pp.3300-3302, 2004.
DOI : 10.1182/blood-2003-11-3852

C. Ross, J. Twisk, and A. Bakker, Correction of Feline Lipoprotein Lipase Deficiency with Adeno-Associated Virus Serotype 1-Mediated Gene Transfer of the Lipoprotein Lipase S447X Beneficial Mutation, Human Gene Therapy, vol.17, issue.5, pp.487-499, 2006.
DOI : 10.1089/hum.2006.17.487

F. Mingozzi, M. Maus, and D. Hui, CD8+ T-cell responses to adeno-associated virus capsid in humans, Nature Medicine, vol.12, issue.4, pp.419-422, 2007.
DOI : 10.1038/nm1549

F. Mingozzi, J. Meulenberg, and D. Hui, AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells, Blood, vol.114, issue.10, pp.2077-2086, 2009.
DOI : 10.1182/blood-2008-07-167510

A. Nathwani, E. Tuddenham, and S. Rangarajan, Adenovirus-Associated Virus Vector???Mediated Gene Transfer in Hemophilia B, New England Journal of Medicine, vol.365, issue.25, pp.2357-2365, 2011.
DOI : 10.1056/NEJMoa1108046

A. Martino, M. Suzuki, and D. Markusic, The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver, Blood, vol.117, issue.24, pp.6459-6468, 2011.
DOI : 10.1182/blood-2010-10-314518

G. Rogers, A. Martino, and I. Zolotukhin, Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B, Journal of Translational Medicine, vol.12, issue.1, p.25, 2014.
DOI : 10.1038/mt.2012.277

F. Mingozzi, Y. Liu, and E. Dobrzynski, Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer, Journal of Clinical Investigation, vol.111, issue.9, pp.1347-1356, 2003.
DOI : 10.1172/JCI200316887

F. Mingozzi, N. Hasbrouck, and E. Basner-tschakarjan, Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver, Blood, vol.110, issue.7, pp.2334-2341, 2007.
DOI : 10.1182/blood-2007-03-080093

A. Toromanoff, O. Adjali, and T. Larcher, Lack of Immunotoxicity After Regional Intravenous (RI) Delivery of rAAV to Nonhuman Primate Skeletal Muscle, Molecular Therapy, vol.18, issue.1, pp.151-160, 2010.
DOI : 10.1038/mt.2009.251

D. Favre, N. Provost, and V. Blouin, Immediate and Long-Term Safety of Recombinant Adeno-associated Virus Injection into the Nonhuman Primate Muscle, Molecular Therapy, vol.4, issue.6, pp.559-566, 2001.
DOI : 10.1006/mthe.2001.0494

V. Arruda, J. Schuettrumpf, and R. Herzog, Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1, Blood, vol.103, issue.1, pp.85-92, 2004.
DOI : 10.1182/blood-2003-05-1446

L. Wang, O. Cao, and B. Swalm, Major role of local immune responses in antibody formation to factor IX in AAV gene transfer, Gene Therapy, vol.246, issue.19, pp.1453-1464, 2005.
DOI : 10.1128/JVI.78.6.3110-3122.2004

L. Wang, R. Calcedo, and P. Bell, Impact of Pre-Existing Immunity on Gene Transfer to Nonhuman Primate Liver with Adeno-Associated Virus 8 Vectors, Human Gene Therapy, vol.22, issue.11, pp.1389-1401, 2011.
DOI : 10.1089/hum.2011.031

A. Toromanoff, Y. Cherel, and M. Guilbaud, Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle, Molecular Therapy, vol.16, issue.7, pp.1291-1299, 2008.
DOI : 10.1038/mt.2008.87

V. Haurigot, F. Mingozzi, and G. Buchlis, Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs, Molecular Therapy, vol.18, issue.7, pp.1318-1329, 2010.
DOI : 10.1038/mt.2010.73

S. Ponnazhagan, G. Mahendra, and D. Curiel, Adeno-Associated Virus Type 2-Mediated Transduction of Human Monocyte-Derived Dendritic Cells: Implications for Ex Vivo Immunotherapy, Journal of Virology, vol.75, issue.19, pp.9493-9501, 2001.
DOI : 10.1128/JVI.75.19.9493-9501.2001

Y. Liu, M. Chiriva-internati, and C. You, Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells, Cancer Gene Therapy, vol.62, issue.3, pp.304-312, 2005.
DOI : 10.1165/ajrcmb.16.3.9070619

W. Aldrich, C. Ren, and A. White, Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands, Gene Therapy, vol.176, issue.1, pp.29-39, 2006.
DOI : 10.1084/jem.176.6.1693

K. Xin, H. Mizukami, and M. Urabe, Induction of Robust Immune Responses against Human Immunodeficiency Virus Is Supported by the Inherent Tropism of Adeno-Associated Virus Type 5 for Dendritic Cells, Journal of Virology, vol.80, issue.24, pp.11899-11910, 2006.
DOI : 10.1128/JVI.00890-06

P. Veron, V. Allo, and C. Riviere, Major Subsets of Human Dendritic Cells Are Efficiently Transduced by Self-Complementary Adeno-Associated Virus Vectors 1 and 2, Journal of Virology, vol.81, issue.10, pp.5385-5394, 2007.
DOI : 10.1128/JVI.02516-06

S. Ohshima, J. Shin, and K. Yuasa, Transduction Efficiency and Immune Response Associated With the Administration of AAV8 Vector Into Dog Skeletal Muscle, Molecular Therapy, vol.17, issue.1, pp.73-80, 2009.
DOI : 10.1038/mt.2008.225

T. Wu, K. Topfer, and S. Lin, Self-complementary AAVs Induce More Potent Transgene Product-specific Immune Responses Compared to a Single-stranded Genome, Molecular Therapy, vol.20, issue.3, pp.572-579, 2012.
DOI : 10.1038/mt.2011.280

K. Jooss, Y. Yang, and K. Fisher, Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers, J Virol, vol.72, pp.4212-4223, 1998.

Y. Zhang, N. Chirmule, and G. Gao, CD40 Ligand-Dependent Activation of Cytotoxic T Lymphocytes by Adeno-Associated Virus Vectors In Vivo: Role of Immature Dendritic Cells, Journal of Virology, vol.74, issue.17, pp.8003-8010, 2000.
DOI : 10.1128/JVI.74.17.8003-8010.2000

D. Xu and C. Walker, Continuous CD8+ T-Cell Priming by Dendritic Cell Cross-Presentation of Persistent Antigen following Adeno-Associated Virus-Mediated Gene Delivery, Journal of Virology, vol.85, issue.22, pp.12083-12086, 2011.
DOI : 10.1128/JVI.05375-11

F. Boisgerault, D. Gross, and M. Ferrand, Prolonged Gene Expression in Muscle Is Achieved Without Active Immune Tolerance Using MicrorRNA 142.3p-Regulated rAAV Gene Transfer, Human Gene Therapy, vol.24, issue.4, pp.393-405, 2013.
DOI : 10.1089/hum.2012.208

A. Majowicz, P. Maczuga, and K. Kwikkers, Mir-142-3p target sequences reduce transgene-directed immunogenicity following intramuscular adeno-associated virus 1 vector-mediated gene delivery, The Journal of Gene Medicine, vol.18, issue.6-7, pp.219-232, 2013.
DOI : 10.1038/gt.2010.157

Y. Lu and S. Song, Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors, Proceedings of the National Academy of Sciences, vol.17, issue.6, pp.17158-17162, 2009.
DOI : 10.1089/hum.2006.17.625

L. Mays, L. Wang, and J. Lin, AAV8 Induces Tolerance in Murine Muscle as a Result of Poor APC Transduction, T Cell Exhaustion, and Minimal MHCI Upregulation on Target Cells, Molecular Therapy, vol.22, issue.1
DOI : 10.1038/mt.2013.134

Z. Wang, T. Zhu, and C. Qiao, Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart, Nature Biotechnology, vol.49, issue.3, pp.321-328, 2005.
DOI : 10.1128/JVI.76.2.791-801.2002

J. Gowans, The recirculation of lymphocytes from blood to lymph in the rat, The Journal of Physiology, vol.146, issue.1, pp.54-69, 1959.
DOI : 10.1113/jphysiol.1959.sp006177

J. Mandl, R. Liou, and F. Klauschen, Quantification of lymph node transit times reveals differences in antigen surveillance strategies of naive CD4+ and CD8+ T cells, Proceedings of the National Academy of Sciences, vol.35, issue.6
DOI : 10.1016/j.immuni.2011.10.017

D. Masopust and J. Schenkel, The integration of T cell migration, differentiation and function, Nature Reviews Immunology, vol.1, issue.5, pp.309-320, 2013.
DOI : 10.1038/mi.2007.9

J. Westermann, S. Persin, and J. Matyas, IFN-gamma influences the migration of thoracic duct B and T lymphocyte subsets in vivo. Random increase in disappearance from the blood and differential decrease in reappearance in the lymph, J Immunol, vol.150, pp.3843-3852, 1993.

V. Blaschke, B. Micheel, and R. Pabst, Lymphocyte traffic through lymph nodes and Peyer's patches of the rat: B- and T-cell-specific migration patterns within the tissue, and their dependence on splenic tissue, Cell & Tissue Research, vol.20, issue.3, pp.377-386, 1995.
DOI : 10.1007/BF00318870

S. Case, M. Price, and C. Jordan, Stable transduction of quiescent CD34+CD38- human hematopoietic cells by HIV-1-based lentiviral vectors, Proceedings of the National Academy of Sciences, vol.91, issue.4, pp.2988-2993, 1999.
DOI : 10.1084/jem.188.6.1117

H. Miyoshi, K. Smith, and D. Mosier, Cells That Mediate Long-Term Engraftment of NOD/SCID Mice by HIV Vectors, Science, vol.73, issue.5402, pp.682-686, 1999.
DOI : 10.1038/nbt0997-871

D. An, R. Wersto, and B. Agricola, Marking and Gene Expression by a Lentivirus Vector in Transplanted Human and Nonhuman Primate CD34+ Cells, Journal of Virology, vol.74, issue.3, pp.1286-1295, 2000.
DOI : 10.1128/JVI.74.3.1286-1295.2000

P. Salmon, V. Kindler, and O. Ducrey, High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors, Blood, vol.96, pp.3392-3398, 2000.

A. Zaiss, M. Cotter, and L. White, Complement Is an Essential Component of the Immune Response to Adeno-Associated Virus Vectors, Journal of Virology, vol.82, issue.6, pp.2727-2740, 2008.
DOI : 10.1128/JVI.01990-07

A. Zaiss and M. Da, Immunity to adeno-associated virus vectors in animals and humans: a continued challenge, Gene Therapy, vol.2007, issue.11, pp.808-816, 2008.
DOI : 10.1182/asheducation-2007.1.466

H. Chen, C. Lilley, and Q. Yu, APOBEC3A Is a Potent Inhibitor of Adeno-Associated Virus and Retrotransposons, Current Biology, vol.16, issue.5, pp.480-485, 2006.
DOI : 10.1016/j.cub.2006.01.031

D. Mccarty, P. Monahan, and R. Samulski, Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis, Gene Therapy, vol.72, issue.16, pp.1248-1254, 2001.
DOI : 10.1016/0006-8993(95)01488-8

E. Cunningham, A. Sharland, and G. Bishop, Liver Transplant Tolerance and Its Application to the Clinic: Can We Exploit the High Dose Effect?, Clinical and Developmental Immunology, vol.64, issue.10, p.419692, 2013.
DOI : 10.1006/smim.2000.0253

J. Mount, R. Herzog, and D. Tillson, Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy, Blood, vol.99, issue.8, pp.2670-2676, 2002.
DOI : 10.1182/blood.V99.8.2670

E. Dobrzynski, J. Fitzgerald, and O. Cao, Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells, Proceedings of the National Academy of Sciences, vol.299, issue.5609
DOI : 10.1126/science.1079490

A. Asokan, J. Johnson, and C. Li, Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals, Gene Therapy, vol.5, issue.24, pp.1618-1622, 2008.
DOI : 10.1016/j.ymthe.2005.11.007

A. Davidoff, J. Gray, and C. Ng, Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models, Molecular Therapy, vol.11, issue.6, pp.875-888, 2005.
DOI : 10.1016/j.ymthe.2004.12.022

H. Nakai, X. Wu, and S. Fuess, Large-Scale Molecular Characterization of Adeno-Associated Virus Vector Integration in Mouse Liver, Journal of Virology, vol.79, issue.6, pp.3606-3614, 2005.
DOI : 10.1128/JVI.79.6.3606-3614.2005

T. Graham, J. Mcintosh, and L. Work, Performance of AAV8 vectors expressing human factor IX from a hepatic-selective promoter following intravenous injection into rats, Genetic Vaccines and Therapy, vol.6, issue.1, p.9, 2008.
DOI : 10.1186/1479-0556-6-9

X. Anguela, S. Tafuro, and C. Roca, Nonviral-Mediated Hepatic Expression of IGF-I Increases Treg Levels and Suppresses Autoimmune Diabetes in Mice, Diabetes, vol.62, issue.2, pp.551-560, 2013.
DOI : 10.2337/db11-1776

A. Annoni, B. Brown, and A. Cantore, In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance, Blood, vol.114, issue.25, pp.5152-5161, 2009.
DOI : 10.1182/blood-2009-04-214569

A. Sharland, G. Logan, and A. Bishop, Liver-directed gene expression using recombinant AAV 2/8 vectors?a tolerogenic strategy for gene delivery, Discov Med, vol.9, pp.519-527, 2010.

A. Sarukhan, S. Camugli, and B. Gjata, Successful Interference with Cellular Immune Responses to Immunogenic Proteins Encoded by Recombinant Viral Vectors, Journal of Virology, vol.75, issue.1, pp.269-277, 2001.
DOI : 10.1128/JVI.75.1.269-277.2001

A. Porgador, D. Snyder, and E. Gilboa, Induction of antitumor immunity using bone marrow-generated dendritic cells, J Immunol, vol.156, pp.2918-2926, 1996.

R. W. Herzog, Complexity of immune responses to AAV transgene products ? Example of factor IX. Cellular Immunology, 2017.

G. Gwladys, W. James, and M. Mueller-christian, Regulatory and Exhausted T Cell Responses to AAV Capsid, Human Gene Therapy, vol.284, pp.338-349, 2017.

C. Addison and S. Taylor-alexander, Gene Editing and Germ-line Intervention: The Need for Novel Responses to Novel Technologies, Molecular Therapy, vol.23, issue.11, pp.1678-1680, 2015.
DOI : 10.1038/mt.2015.185

M. Ferrand, S. Da-rocha, G. Corre, A. Galy, and F. Boisgerault, Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors, Molecular Therapy, vol.23, issue.6, pp.1022-1033, 2015.
DOI : 10.1038/mt.2015.59